Novel Conjugates Summit 2025

This event has passed.

Novel Conjugates Summit 2025

The field of conjugatable drugs is advancing at a rapid pace, with major collaborations like Nurix & Pfizer for antibody-degrader conjugates and Bicycle & Novartis for radiopharmaceuticals, which paves the way towards a new generation of more targeted, safer and efficacious novel conjugated drugs.

See who is attending

Seema Zaidi

Senior Manager, Business Development

Keith Porter

Senior Manager, Business Development

Joseph Fraone

Senior Manager, Business Development

Upcoming Events